Public Employees Retirement System of Ohio Makes New Investment in Chemed Corporation $CHE

Public Employees Retirement System of Ohio bought a new stake in shares of Chemed Corporation (NYSE:CHE) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 4,032 shares of the company’s stock, valued at approximately $1,878,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Capstone Investment Advisors LLC bought a new position in shares of Chemed in the second quarter worth approximately $547,000. Corient Private Wealth LP bought a new stake in Chemed during the second quarter worth about $1,259,000. Punch & Associates Investment Management Inc. purchased a new stake in shares of Chemed in the 2nd quarter worth approximately $219,000. Bank of America Corp DE purchased a new stake in shares of Chemed in the second quarter worth $48,255,000. Finally, Caisse de depot et placement du Quebec purchased a new stake in Chemed during the 2nd quarter valued at about $44,309,000. 95.85% of the stock is currently owned by institutional investors.

Chemed Trading Up 0.2%

CHE stock opened at $520.82 on Monday. The firm’s 50-day moving average is $516.70 and its 200 day moving average is $451.67. The company has a market capitalization of $6.81 billion, a PE ratio of 26.16, a P/E/G ratio of 1.97 and a beta of 0.51. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the prior year, the business earned $4.27 EPS. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were paid a dividend of $0.70 per share. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 14.06%.

Analyst Ratings Changes

A number of analysts have commented on the company. Oppenheimer lifted their target price on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Royal Bank Of Canada raised their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $530.75.

Insider Activity

In related news, CEO Kevin McNamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares in the company, valued at $38,107,404.88. The trade was a 2.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Andrea Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 6,537 shares of company stock valued at $3,406,014 over the last 90 days. 3.33% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.